pharma · H Pylori Infection · H. Pylori Infection · PHAT
Phathom Pharmaceuticals
Phathom Pharmaceuticals clinical programs — 5 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 100 Campus Drive, Suite 102, Florham Park, New Jersey 07932, US
- Founded
- 2018
- Employees
- 420
- Programs
- 11
- Drugs
- 5
- Patents
- 8
Phathom Pharmaceuticals projects
5 ClinicalTrials.gov programs sponsored by Phathom Pharmaceuticals.
Phathom Pharmaceuticals has 5 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Vonoprazan
Phathom Pharmaceuticals
Gastroesophageal Reflux
1 trial -
Vonoprazan
Phathom Pharmaceuticals
Gastroesophageal Reflux Disease
1 trial -
Vonoprazan
Phathom Pharmaceuticals
Healthy Participants
2 trials -
Vonoprazan
Phathom Pharmaceuticals
Healthy Volunteers
2 trials -
Vonoprazan ODT-1 or ODT-2 without Water
Phathom Pharmaceuticals
Healthy Volunteers
1 trial
Frequently asked questions
How many clinical projects does Phathom Pharmaceuticals have?
5 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.